The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

Policy Notices

• Notice of Transition to New System for Issuing Certificates of Confidentiality for Non-NIH Funded Research
  National Institutes of Health

General Notices

• The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) Announces Regional Workshop on Sexual and Gender Minority (SGM)-Related Health Research
  Office of the Director, NIH

• Request for Information (RFI) on Implementation of the Updated AVMA Guidelines for the Euthanasia of Animals: 2020 Edition
  National Institutes of Health

Notice of Changes to Funding Opportunities

• Notice to update NIH HIV/AIDS Research Priorities and Guidelines in NOT-AR-20-005, "Notice of Special Interest: Promoting research opportunities on HIV/AIDS in NIAMS."
  National Institute of Arthritis and Musculoskeletal and Skin Diseases

• Notice of NIDDK Withdrawal from Participation in PA-19-116 "Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)"
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice of Change to the Application Due Date for PAR-20-105 titled "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed"
  Food and Drug Administration

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required)
  NIH Basic Behavioral and Social Science Opportunity Network
  National Center for Complementary and Integrative Health
  Office of Behavioral and Social Sciences Research

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations with the NCI-supported Drug Resistance and Sensitivity Network (DRSN)
  National Cancer Institute

• Notice of Special Interest (NOSI): Going Global: Using Gene Network Analyses to Understand the Etiology of SUD
  National Institute on Drug Abuse

• Notice of Special Interest (NOSI): Administrative Supplements for Research on Womens Health in the IDeA States
  National Institute of General Medical Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute of Nursing Research
  Office of Research on Women's Health

• Notice of Special Interest (NOSI): Availability of Administrative Supplements for the NNLM Web Services Office, Training Office, and the Evaluation Office to Support NNLM All of Us Activities.
  National Library of Medicine

• Notice of Special Interest (NOSI): Availability of Administrative Supplements for the Rare Disease Clinical Research Network (RDCRN)
  National Center for Advancing Translational Sciences
  National Heart, Lung, and Blood Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke

Funding Opportunities

• Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)
  National Cancer Institute
   
• Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)
  National Institute of General Medical Sciences
   
• National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional)
• National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U19 Clinical Trial Optional)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  
   
• Alzheimers Disease Sequencing Project Functional Genomics Consortium (U01 Clinical Trial Not Allowed)
  National Institute on Aging
   
• National Longitudinal Study of Adolescent to Adult Health (Add Health) Wave 6 (U01 Clinical Trial Not Allowed)
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute on Minority Health and Health Disparities 
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
   
• Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)
  National Institute on Aging
   
• Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed)
  National Institute of Allergy and Infectious Diseases
   
• Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional)
  National Institute of Allergy and Infectious Diseases
   
• Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)
  National Institute of Allergy and Infectious Diseases
    
• Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
  National Institute of Allergy and Infectious Diseases
   
• Exploring the Roles of Biomolecular Condensates (BMCs) in HIV replication, latency, or pathogenesis in the context of substance use disorders (R21/R33 Clinical Trial Not Allowed)
  National Institute on Drug Abuse
   
• Contraceptive Development Research Centers (CDRC) Program (P50 Clinical Trial Optional)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
   
• BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
   
• Limited Competition: Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 Clinical Trial Not Allowed)
  Only one application per institution is allowed. Eligible applicant institutions for this FOA are limited to recipients of RCMI awards through RFA-MD-17-003, RFA-MD-17-006, RFA-MD-18-012, or PAR-11-132.
  National Institute on Minority Health and Health Disparities 

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu